4374-62-3Relevant articles and documents
Mechanistic investigation of the selective reduction of Meldrum's acids to β-hydroxy acids using SmI2 and H2O
Szostak, Michal,Lyons, Sarah E.,Spain, Malcolm,Procter, David J.
supporting information, p. 8391 - 8394 (2014/07/22)
The mechanism of a recently reported first mono-reduction of cyclic 1,3-diesters (Meldrum's acids) to β-hydroxy acids with SmI 2-H2O has been studied using a combination of reactivity, deuteration, kinetic isotope and radical clock e
Selective reductions of cyclic 1,3-diesters by using SmI2 and H2O
Collins, Karl D.,Oliveira, Juliana M.,Guazzelli, Giuditta,Sautier, Brice,De Grazia, Sara,Matsubara, Hiroshi,Helliwell, Madeleine,Procter, David J.
scheme or table, p. 10240 - 10249 (2010/11/18)
SmI2/H2O reduces cyclic 1,3-diesters to 3-hydroxyacids with no over reduction. Furthermore, the reagent system is selective for cyclic 1,3-diesters over acyclic 1,3-diesters, and esters. Radicals formed by one-electron reduction of the ester carbonyl group have been exploited in intramolecular additions to alkenes. The ketal unit and the reaction temperature have a marked impact on the diastereoselectivity of the cyclizations. Cyclization cascades are possible when two alkenes are present in the starting cyclic diester and lead to the formation of two rings and four stereocenters with excellent stereocontrol.
Process for preparation of an optically active β-mercaptoalkanoic acid
-
, (2008/06/13)
A process is disclosed wherein an optically active β-mercaptoalkanoic acid represented by formula (I): STR1 wherein R1 is lower alkyl having from 1 to 4 carbon atoms, is prepared by (1) reacting an optically active β-hydroxyalkanoic acid represented by formula (II): STR2 wherein R1 is the same as defined above, with a halogenating reagent to prepare an optically active β-haloalkanoyl halide represented by formula (III): STR3 wherein X is halogen and R1 is the same as defined above; (2) reacting the β-haloalkanoyl halide with water or an aqueous alkaline solution to prepare an optically active β-haloalkanoic acid represented by formula (IV): STR4 wherein X and R1 are each the same as defined above, or a salt thereof, respectively; and (3) reacting the β-haloalkanoic acid or the salt thereof with a reagent capable of converting the halogen into the thiol group, the configuration of the compound (II), (III), and (IV) being retained throughout the process to prepare the compound represented by formula (I). The product of the present invention is useful as an intermediate for preparation of an antihypertensive agent such as N-(3-mercapto-2-D-methylpropanoyl)-L-proline.